US Bancorp’s Signify Health, Inc. SGFY Stock Holding History

US Bancorp’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-800	Closed	-$22.9K	–	4235
2022 Q4	$22.9K	Buy	800 +791	+8,789%	+$22.8K	﹤0.01%	2929
2022 Q3	$0	Buy	+9	New	+$207	﹤0.01%	4282
2022 Q1	–	Sell	-1,576	Closed	-$22K	–	4263
2021 Q4	$22K	Hold	1,576	–	–	﹤0.01%	3077
2021 Q3	$28K	Buy	1,576 +586	+59%	+$15.1K	﹤0.01%	2955
2021 Q2	$30K	Buy	990 +155	+19%	+$4.26K	﹤0.01%	2936
2021 Q1	$24K	Buy	+835	New	+$25.8K	﹤0.01%	2952

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

US Bancorp's SGFY Position: Q1 2023 in Review

US Bancorp sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 800 shares — an estimated $22.9K sold.

US Bancorp first reported a position in SGFY in Q1 2021 and held it in 6 quarters. The position peaked at $30K in Q2 2021. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

US Bancorp reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
US Bancorp sold 800 Signify Health, Inc. shares in Q1 2023, an estimated $22.9K.
US Bancorp first reported a position in Signify Health, Inc. in Q1 2021 and held it in 6 quarters.
US Bancorp's Signify Health, Inc. position peaked at $30K in Q2 2021.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.